In recent years, a number of studies have verified the efficacy of these approved drugs for various IL-1-related diseases, including autoimmune diseases such as osteoarthritis, gout, juvenile idiopathic arthritis, and diabetes [9, 10]. The gene discussed is IL1B; the disease is osteoarthritis.